首页> 外文期刊>Peptides: An International Journal >Intravenous phage display identifies peptide sequences that target the burn-injured intestine
【24h】

Intravenous phage display identifies peptide sequences that target the burn-injured intestine

机译:静脉内噬菌体展示可鉴定靶向烧伤肠的肽序列

获取原文
获取原文并翻译 | 示例
           

摘要

The injured intestine is responsible for significant morbidity and mortality after severe trauma and burn; however, targeting the intestine with therapeutics aimed at decreasing injury has proven difficult. We hypothesized that we could use intravenous phage display technology to identify peptide sequences that target the injured intestinal mucosa in a murine model, and then confirm the cross-reactivity of this peptide sequence with ex vivo human gut. Four hours following 30% TBSA burn we performed an in vivo, intravenous systemic administration of phage library containing 1012 phage in balb/c mice to biopan for gut-targeting peptides. In vivo assessment of the candidate peptide sequences identified after 4 rounds of internalization was performed by injecting 1 × 1012 copies of each selected phage clone into sham or burned animals. Internalization into the gut was assessed using quantitative polymerase chain reaction. We then incubated this gut-targeting peptide sequence with human intestine and visualized fluorescence using confocal microscopy. We identified 3 gut-targeting peptide sequences which caused collapse of the phage library (4-1: SGHQLLLNKMP, 4-5: ILANDLTAPGPR, 4-11: SFKPSGLPAQSL). Sequence 4-5 was internalized into the intestinal mucosa of burned animals 9.3-fold higher than sham animals injected with the same sequence (2.9 × 105 vs. 3.1 × 104 particles per mg tissue). Sequences 4-1 and 4-11 were both internalized into the gut, but did not demonstrate specificity for the injured mucosa. Phage sequence 4-11 demonstrated cross-reactivity with human intestine. In the future, this gut-targeting peptide sequence could serve as a platform for the delivery of biotherapeutics.
机译:严重的外伤和烧伤后,受伤的肠道导致大量发病和死亡。然而,事实证明,以减少伤害的治疗方法靶向肠道是困难的。我们假设我们可以使用静脉噬菌体展示技术来鉴定靶向鼠模型中受损肠粘膜的肽序列,然后确认该肽序列与离体人肠道的交叉反应性。在30%TBSA烧伤后四个小时,我们对balb / c小鼠体内含1012个噬菌体的噬菌体文库进行了体内静脉内全身给药,以生物淘选肠靶向肽。通过将每个选定的噬菌体克隆的1×1012拷贝注射到假动物或烧伤的动物中,进行4轮内化后鉴定的候选肽序列的体内评估。使用定量聚合酶链反应评估进入肠道的内在化。然后,我们将这种肠靶向肽序列与人肠一起温育,并使用共聚焦显微镜观察荧光。我们鉴定了3种肠靶向肽序列,它们导致噬菌体文库的崩溃(4-1:SGHQLLLNKMP,4-5:ILANDLTAPGPR,4-11:SFKPSGLPAQSL)。序列4-5被内化到烧伤动物的肠粘膜中,比注射相同序列的假动物高9.3倍(每毫克组织2.9×105对3.1×104颗粒)。序列4-1和4-11都被内化到肠中,但是没有显示出对受损粘膜的特异性。噬菌体序列4-11表现出与人肠的交叉反应性。将来,这种靶向肠道的肽序列可以作为生物治疗药物递送的平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号